Douglas C. Beshore

1.1k total citations
29 papers, 750 citations indexed

About

Douglas C. Beshore is a scholar working on Molecular Biology, Organic Chemistry and Cancer Research. According to data from OpenAlex, Douglas C. Beshore has authored 29 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Organic Chemistry and 5 papers in Cancer Research. Recurrent topics in Douglas C. Beshore's work include Chemical synthesis and alkaloids (6 papers), Receptor Mechanisms and Signaling (5 papers) and Chemical Synthesis and Analysis (4 papers). Douglas C. Beshore is often cited by papers focused on Chemical synthesis and alkaloids (6 papers), Receptor Mechanisms and Signaling (5 papers) and Chemical Synthesis and Analysis (4 papers). Douglas C. Beshore collaborates with scholars based in United States, United Kingdom and Belgium. Douglas C. Beshore's co-authors include Christopher J. Dinsmore, Amos B. Smith, Scott D. Kuduk, George D. Hartman, Christopher P. Regan, Charles McIntyre, Laszlo Kiss, Gary L. Stump, Joseph J. Lynch and Onur Atasoylu and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Douglas C. Beshore

28 papers receiving 723 citations

Peers

Douglas C. Beshore

PHARM

CMN

CCM

Yong‐Jin Wu United States

Brian A. McKittrick United States

Dieter Hamprecht United Kingdom

Hun Yeong Koh South Korea

Oreste Livi Italy

Karl R. Gibson United Kingdom

Isabella Fiorini Italy

Michel Thérien Canada

Oleg D. Mitkin Russia

Grant McNaughton‐Smith Spain

Yong‐Jin Wu United States

Douglas C. Beshore

714 ×1.6

265 ×0.7

98 ×0.9

PHARM

69 ×0.8

CMN

40 ×0.7

CCM

Citations per year, relative to Douglas C. Beshore Douglas C. Beshore (= 1×) peers Yong‐Jin Wu

Countries citing papers authored by Douglas C. Beshore

Since Specialization

Citations

This map shows the geographic impact of Douglas C. Beshore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas C. Beshore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas C. Beshore more than expected).

Fields of papers citing papers by Douglas C. Beshore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas C. Beshore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas C. Beshore. The network helps show where Douglas C. Beshore may publish in the future.

Co-authorship network of co-authors of Douglas C. Beshore

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas C. Beshore. A scholar is included among the top collaborators of Douglas C. Beshore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas C. Beshore. Douglas C. Beshore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Citron, Michael, Meng Shi, William Rose, et al.. (2024). Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals models. Journal of Infection. 89(6). 106325–106325. 1 indexed citations

Fischmann, Thierry, John A. Howe, Douglas C. Beshore, et al.. (2023). Conserved allosteric inhibitory site on the respiratory syncytial virus and human metapneumovirus RNA-dependent RNA polymerases. Communications Biology. 6(1). 649–649. 20 indexed citations

Beshore, Douglas C., Andrew M. Haidle, Ashok Arasappan, et al.. (2022). Building a Culture of Medicinal Chemistry Knowledge Sharing. Journal of Medicinal Chemistry. 65(5). 3776–3785. 1 indexed citations

Beshore, Douglas C., Gregory C. Adam, Richard J. O. Barnard, et al.. (2021). Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor Interaction. ACS Medicinal Chemistry Letters. 12(4). 540–547. 14 indexed citations

Yu, Wensheng, Jian Liu, Younong Yu, et al.. (2020). Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation. Bioorganic & Medicinal Chemistry Letters. 30(13). 127197–127197. 22 indexed citations

Uslaner, Jason M., Scott D. Kuduk, Marion Wittmann, et al.. (2018). Preclinical to Human Translational Pharmacology of the Novel M1 Positive Allosteric Modulator MK-7622. Journal of Pharmacology and Experimental Therapeutics. 365(3). 556–566. 31 indexed citations

Kuduk, Scott D., Christina N. Di Marco, William J. Ray, et al.. (2014). Identification of a methoxynaphthalene scaffold as a core replacement in quinolizidinone amide M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 24(5). 1417–1420. 7 indexed citations

Kuduk, Scott D. & Douglas C. Beshore. (2014). SAR Studies on Carboxylic Acid Series M<sub>1</sub> Selective Positive Allosteric Modulators (PAMs). Current Topics in Medicinal Chemistry. 14(15). 1738–1754. 10 indexed citations

Kuduk, Scott D. & Douglas C. Beshore. (2012). Novel M₁allosteric ligands: a patent review. Expert Opinion on Therapeutic Patents. 22(12). 1385–1398. 26 indexed citations

10.

Beshore, Douglas C., Nigel J. Liverton, Charles McIntyre, et al.. (2010). Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorganic & Medicinal Chemistry Letters. 20(8). 2493–2496. 12 indexed citations

11.

Kuduk, Scott D., Robert M. DiPardo, Douglas C. Beshore, et al.. (2010). Hydroxy cycloalkyl fused pyridone carboxylic acid M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(8). 2538–2541. 15 indexed citations

12.

Smith, Amos B., Onur Atasoylu, & Douglas C. Beshore. (2009). Construction of 5,6-Ring-Fused 2-Pyridones: An Effective Annulation Tactic Achieved in Water. Synlett. 2009(16). 2643–2646. 28 indexed citations

13.

Beshore, Douglas C., Robert M. DiPardo, & Scott D. Kuduk. (2009). Preparation of 2,4,5-trisubstituted pyrazolo[4,3-c]quinolin-3-ones. Tetrahedron Letters. 51(6). 970–973. 7 indexed citations

14.

Beshore, Douglas C. & Amos B. Smith. (2008). The Lyconadins: Enantioselective Total Syntheses of (+)-Lyconadin A and (−)-Lyconadin B. Journal of the American Chemical Society. 130(41). 13778–13789. 41 indexed citations

15.

Regan, Christopher P., Laszlo Kiss, Gary L. Stump, et al.. (2007). Atrial Antifibrillatory Effects of Structurally Distinct IKur Blockers 3-[(Dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2 H)-one and 2-Phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in Dogs with Underlying Heart Failure. Journal of Pharmacology and Experimental Therapeutics. 324(1). 322–330. 28 indexed citations

16.

Beshore, Douglas C. & Amos B. Smith. (2007). Synthesis of (+)-Lyconadin A. Synfacts. 2007(8). 791–791.

17.

Beshore, Douglas C. & Christopher J. Dinsmore. (2003). Preparation of Ethyl 5-Iodo-1H-indole- 2-carboxylate. Synthetic Communications. 33(14). 2423–2427. 7 indexed citations

18.

Beshore, Douglas C. & Christopher J. Dinsmore. (2002). Preparation of Substituted Piperazinones via Tandem Reductive Amination−(N,N‘-Acyl Transfer)−Cyclization. Organic Letters. 4(7). 1201–1204. 31 indexed citations

19.

Dinsmore, Christopher J. & Douglas C. Beshore. (2002). Recent advances in the synthesis of diketopiperazines. Tetrahedron. 58(17). 3297–3312. 165 indexed citations

20.

Bell, Ian M., Douglas C. Beshore, Steven N. Gallicchio, & Theresa M. Williams. (2000). Efficient synthesis of 1-heterocyclic-3-aminopyrrolidinones. Tetrahedron Letters. 41(8). 1141–1145. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact